Abstract
Manus Bio has received a fourth award from the Bill and Melinda Gates Foundation to develop a biobased route to the antimalarial drug artemisinin. The industrial biotech firm says the $2 million award will help it scale up its process for a key intermediate, dihydroartemisinic acid. Artemisinin is now extracted from sweet wormwood, but availability of the plant is subject to the vagaries of farming, Manus says.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call